Healthcare
Live Price
Offline$0.001
+0.00% today
1Y Change
+900.00%
Window
Jun 23, 2025 → Jun 12, 2026
Coverage: 248 bars · Jun 23, 2025 → Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rafina Innovations Inc. (VICA) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 900.0% across the available one-year price window (Jun 23, 2025 → Jun 12, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of -226.5%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS -226.5%, free cash flow -2163.3% with operating margin -26.6% and ROIC -19.6%. Valuation is more restrained than many high-expectation growth names at price/sales 0.0. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines VICA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
VICA
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
VICA Max Drawdown
-70.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for VICA and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$355.7K
-13.8% YoY
FY Net Income
-$3.0M
+48.9% YoY
Free Cash Flow
-$739.6K
+19.5% YoY
Revenue Growth
+0.0%
EPS Growth
-226.5%
Gross Margin
-5.2%
Net Margin
-26.9%
Income statement
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Revenue | 3M | 0 | 56K | 413K | 356K |
| Gross Profit | -169K | -47K | 53K | 268K | 226K |
| Operating Income | -868K | -61K | -1M | -4M | -3M |
| EBITDA | -856K | -14K | -1M | -6M | -3M |
| Net Income | -879K | -85K | -1M | -6M | -3M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|
| Cash & Equivalents | 16K | 2K | 4K | 19K | 352K |
| Total Assets | 8M | 192K | 241K | 299K | 650K |
| Total Liabilities | 4M | 1M | 1M | 793K | 2M |
| Shareholder Equity | 4M | -869K | -1M | -494K | -911K |
| Total Debt | 333K | 691K | 690K | 79K | 48K |
| Net Debt | 317K | 689K | 687K | 60K | -305K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
740K
+19.5% YoY
Capital Expenditures
0
Free Cash Flow
740K
+19.5% YoY
Key ratios
Gross Margin
-5.2%
Operating Margin
-26.6%
Net Margin
-26.9%
ROE
-55.5%
Debt / Equity
0.08x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.